Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#3043 Angiogenetic Markers as Prognostic Predictors in Neuroendocrine Neoplasms
Introduction: Neoangiogenesis is crucial for NEN development and metastatization.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Puliani G
Authors: Puliani G, Feola T, Sesti F, Sciarra F, Campolo F,
Keywords: biomarkers, prognosis,
Introduction: Sst5TMD4, which is derived from a non-canonical splicing process of sst5 receptor, is overexpressed in several endocrine tumors and associated with a worse prognosis.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Diaz Perez A, Martínez-Fuentes A, García-Carbonero R, Luque R, Jimenez-Fonseca P,
Keywords: somatostatin receptor, neuroendocrine tumors,
Introduction: More than 10% of patient treated with Everolimus develop early onset of resistance. The lacking of adequate predictive factors in the targeted hera makes challenging the early identification of non-responders patients.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: cella c
Authors: Cella C, Spada F, Labanca V, Radice D, Rubino M,
Keywords: pancreatic nets, biomarker, everolimus,
Introduction: Platelets carry VEGF-A, serotonin and dopamine. Serotonin stimulates and dopamine inhibits tumor angiogenesis. We hypothesized that platelets are activated in tumor vasculature and release angiogenic factors, resulting in lower platelet serotonin and dopamine.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author:
Authors: Peters M, Van Faassen M, Van Asselt S, Bouma G, Meijer C,
Keywords: Serotonin, dopamine, pancreatic neuroendocrine tumor, renal cell carcinoma.,
Introduction: Recent data show a characteristic pattern of selected angiogenic factors of plasma levels: endostatin(END), osteopontin(OPN), angiopoietin 1 & 2 (Ang-1&2) in patients with neuroendocrine neoplasm (NEN) in comparison to healthy controls.
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author:
Authors: Mełen-Mucha G, Musial J, Kordek R, Stepien H,
Keywords: NEN, angiogenic factors, IHC,